U.S. Markets closed

Analysts Raise Neurocrine Biosciences’ Target Price in March

Margaret Patrick
Analysts Raise Neurocrine Biosciences’ Target Price in March

Analysts Are Feeling Good about These Biotech Stocks in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 26.66% for Neurocrine Biosciences (NBIX) based on the company’s